Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04104893
Title A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation (CHOMP)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors VA Office of Research and Development
Indications

prostate adenocarcinoma

prostate small cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST